These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35008897)

  • 21. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
    Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
    J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.
    Kawahara G; Gasperini MJ; Myers JA; Widrick JJ; Eran A; Serafini PR; Alexander MS; Pletcher MT; Morris CA; Kunkel LM
    Hum Mol Genet; 2014 Apr; 23(7):1869-78. PubMed ID: 24234649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.
    Young CN; Sinadinos A; Lefebvre A; Chan P; Arkle S; Vaudry D; Gorecki DC
    Autophagy; 2015; 11(1):113-30. PubMed ID: 25700737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.
    Baechler BL; Bloemberg D; Quadrilatero J
    Autophagy; 2019 Sep; 15(9):1606-1619. PubMed ID: 30859901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.
    Hindi SM; Sato S; Choi Y; Kumar A
    Hum Mol Genet; 2014 Mar; 23(6):1492-505. PubMed ID: 24163132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene.
    Polak K; Stępniewski J; Ścieżyńska A; Podgórska A; Dulak J; Florczyk-Soluch U
    Stem Cell Res; 2023 Feb; 66():103004. PubMed ID: 36565681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in
    Swiderski K; Read SJ; Chan AS; Chung JD; Trieu J; Naim T; Koopman R; Lynch GS
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
    Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy as a new therapeutic target in Duchenne muscular dystrophy.
    De Palma C; Morisi F; Cheli S; Pambianco S; Cappello V; Vezzoli M; Rovere-Querini P; Moggio M; Ripolone M; Francolini M; Sandri M; Clementi E
    Cell Death Dis; 2012 Nov; 3(11):e418. PubMed ID: 23152054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.